Lumos Pharma, Inc. Banner Image

Lumos Pharma, Inc.

  • Ticker LUMO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Lumos Pharma, Inc. Logo Image
  • 11-50 Employees
  • Based in Austin, Texas
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. The Company was founded and is led by a management team with longstanding experience in rare disease drug development. Lumos Pharma’s lead therapeutic candidate, LUM-201, is a novel, oral growth hormone (GH) secretagogue, seeking to transformMore the $4.5B global GH market from injectable to oral therapy. LUM-201 is currently being evaluated in multiple Phase 2 clinical studies in Pediatric Growth Hormone Deficiency (PGHD) and has received Orphan Drug Designation in both the US and EU.
Lumos Pharma, Inc.

Most Recent Annual Report

Lumos Pharma, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Lumos Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!